Artal Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-275,000
| Closed | -$11.3M | – | 72 |
|
|
2024
Q2 | $11.3M | Buy |
275,000
+97,068
| +55% | +$3.99M | 0.29% | 37 |
|
|
2024
Q1 | $8.31M | Buy |
+177,932
| New | +$8.31M | 0.21% | 48 |
|
|
2017
Q4 | – | Sell |
-50,000
| Closed | -$2.66M | – | 102 |
|
|
2017
Q3 | $2.66M | Hold |
50,000
| – | – | 0.05% | 58 |
|
|
2017
Q2 | $3.11M | Buy |
50,000
+20,000
| +67% | +$1.24M | 0.05% | 55 |
|
|
2017
Q1 | $2.03M | Sell |
30,000
-20,000
| -40% | -$1.36M | 0.05% | 61 |
|
|
2016
Q4 | $3.52M | Hold |
50,000
| – | – | 0.08% | 38 |
|
|
2016
Q3 | $3.55M | Sell |
50,000
-25,000
| -33% | -$1.77M | 0.07% | 43 |
|
|
2016
Q2 | $3.67M | Buy |
+75,000
| New | +$3.67M | 0.08% | 35 |
|